TW Wiegand, AH Rogers, F McCabe, E Reichel, … - British Journal of …, 2009 - bjo.bmj.com Results: With a mean follow-up of 19 months (range 10 to 28 months), the best corrected visual
acuity improved by three or more lines in four eyes (44.4%), remained within two lines of baseline
in four eyes (44.4%) and decreased by three or more lines in one eye (11.1%). Central ... Cited by 5 - Related articles - All 4 versions
- ►prsjournal.com P Neri, S Salvolini, C Mariotti, L Mercanti, S … - British Journal of …, 2009 - bjo.bmj.com Methods: Patients with unilateral active CNV associated with AS were enrolled. Exclusion criteria
were previous treatment for CNV and comorbidity. Postoperative visual acuity was defined as
a gain or loss of two or more lines of best-corrected visual acuity (BCVA). Post-treatment ... Cited by 4 - Related articles - All 4 versions
MC Donati, G Virgili, A Bini, F Giansanti, E Rapizzi, … - …, 2009 - content.karger.com Background: Intravitreal (IV) bevacizumab (Avastin®, Roche), initially used for the off-label treatment
of neovascular age-related macular degeneration (AMD), has extended itself to treat various
ocular pathologies such as choroidal neovascularization not associated to AMD. ... Cited by 2 - Related articles - All 4 versions
JM Monés, L Amselem, A Serrano, M Garcia, M Hijano - Eye, 2009 - nature.com There were 23 eyes of 23 patients, and the mean age was 51.08 (SD=17.40) years. One patient
was lost during the follow-up. At the 12-month follow-up, the mean VA improved by 9.53 letters
(P<0.05). In all, 69% of patients increased at least one line, and 34.7% increased three or ... Cited by 3 - Related articles - All 3 versions
A Streaks - bjo.bmj.com Page 1. doi: 10.1136/bjo.2008.143461 published online October 29, 2008 Br J Ophthalmol Torsten
W Wiegand, Adam H Rogers, Frank McCabe, et al. Angioid Streaks Choroidal Neovascularization
in Patients with Intravitreal Bevacizumab (Avastin) Treatment of ... Related articles
AC Browning, WM Amoaku, AK Chung, F Ghanchi, SP … - Ophthalmology, 2007 - Elsevier The patient demographics and baseline characteristics have been reported previously. Sixteen
eyes with subfoveal choroidal neovascularization and 7 with juxtafoveal lesions at baseline were
recruited. Twenty-two eyes of 21 patients were examined at 3-month intervals up to 24 ... Cited by 4 - Related articles - All 7 versions
S Mandal, S Garg, P Venkatesh, C Mithal, … - Archives of …, 2007 - archopht.highwire.org You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Add to CiteULike Add to Connotea Add to ... Cited by 12 - Related articles - BL Direct - All 3 versions
M Sawa, F Gomi, M Tsujikawa, H Sakaguchi, Y … - American Journal of …, 2009 - Elsevier The mean follow-up was 19 months (range, 12 to 24 months). The mean number of injections
for primary CNV was 4.5 (range, 1 to 9). The mean preoperative BCVA (decimal equivalent) was
0.39 (range, 0.08 to 1.5) and 0.47 (range, 0.06 to 1.2) at the final visit (P = .355). The ... Related articles - All 12 versions
B Gupta, M Elagouz, S Sivaprasad - Eye, 2009 - nature.com Choroidal neovascularisation (CNV) is characterised by new blood vessel growth under the
retina that usually results in significant visual impairment when the fovea is involved. Though
CNV is more commonly associated with age-related macular degeneration (AMD), it can ... Related articles - All 3 versions
